Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Wan

Showing results (481-490 of 491) with videos related to

Pageof 50
Sort By:
Plos Biology|August 26, 2025
MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosingIzzat T Raheem, Vinay Girijavallabhan, Kerry L Fillgrove, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureMichael T Rudd, John A McCauley, John W Butcher, et al.
Nature|September 9, 2021
The EDS1-PAD4-ADR1 node mediates Arabidopsis pattern-triggered immunityRory N Pruitt, Federica Locci, Friederike Wanke, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motifDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Journal of Medicinal Chemistry|February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitorJohn A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkersMichael T Rudd, Charles J McIntyre, Joseph J Romano, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2012
Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A proteaseMichael T Rudd, John A McCauley, Joseph J Romano, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
The New England Journal of Medicine|March 18, 2011
Fever with thrombocytopenia associated with a novel bunyavirus in ChinaXue-Jie Yu, Mi-Fang Liang, Shou-Yin Zhang, et al.
Pageof 50

Showing results (481-490 of 491) with videos related to

Sort By:
Pageof 50
Plos Biology|August 26, 2025
MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosingIzzat T Raheem, Vinay Girijavallabhan, Kerry L Fillgrove, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureMichael T Rudd, John A McCauley, John W Butcher, et al.
Nature|September 9, 2021
The EDS1-PAD4-ADR1 node mediates Arabidopsis pattern-triggered immunityRory N Pruitt, Federica Locci, Friederike Wanke, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motifDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Journal of Medicinal Chemistry|February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitorJohn A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkersMichael T Rudd, Charles J McIntyre, Joseph J Romano, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2012
Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A proteaseMichael T Rudd, John A McCauley, Joseph J Romano, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
The New England Journal of Medicine|March 18, 2011
Fever with thrombocytopenia associated with a novel bunyavirus in ChinaXue-Jie Yu, Mi-Fang Liang, Shou-Yin Zhang, et al.
Pageof 50